TORONTO–(BUSINESS
WIRE)–At the worlds largest medical trade fair, Medica 2011 held in Düsseldorf last week, CardioComm Solutions, Inc. (TSX-V: EKG) demonstrated their
newly developed remote patient ECG monitoring service, called HeartCheckTM
Smart Monitoring (Smart Monitoring). Smart Monitoring uses CardioComms new
application programming interface (API), and their established C4™ (CardioComm Coordinating Centre) arrhythmia and ECG
management service to interact with handheld patient-activated ECG monitoring
devices.
How the Solution Works
CardioComm Solutions new API works specifically with the FDA-cleared and
CE-certified HeartCheck™ ECG monitor. The HeartCheckTM ECG monitor functions as
an arrhythmia as well as a resting ECG monitor, providing a function much like
a digital thermometer for the heart. Other such devices may connect via cell
phone or over the internet, and enable individuals to record and store their
ECGs, but the critical question often asked is who will review these ECGs and
how?
“At CardioComm,” said CEO Etienne Grima, “weve developed
FDA-cleared and CE-approved solutions to answer these two questions. We can
transmit these ECGs under a standardized format in such a manner that
physicians have rapid access to review them and provide a medical
interpretation or recommendation for how patients should proceed.
“Using a handheld ECG device is not new,” added Grima. “What
is new is that with our proven C4 technology, patients now have the unique
capacity to securely connect over the internet and within minutes have their
ECGs accessed by physicians from anywhere in the world. The significance of
this is the existence of a large population of consumers with chronic
conditions (the 3C market) who own or wish to purchase devices that can assist
in monitoring their heart health.”
Medica Demo
At Medica 2011, CardioComm demonstrated the interoperability between C4 and the
handheld ECG monitor to several companies, recording ECGs while at the congress
in Germany and transmitting them to CardioComms server facilities in Canada.
The ECG recordings were then reviewed within minutes through the physician
portal for C4.
“The responses we received at Medica were very
enthusiastic,” said Grima, “and we anticipate future opportunities to integrate
our C4 software service as a preferred back-end ECG management solution with
several devices. We intend to develop a virtual server support system in
different countries in order to adhere to those countries requirements for the
control of personal health records.
“At CardioComm, were committed to being a preferred
solution for everything that is ECG, and to address the 3C market,” said Grima.
“We continue to develop new products and services, many of which will be
released in 2012, including expansion of our traditional PC- and LAN-based
solutions that will be Window 7 and Windows Server 2008 compatible.”
This solution marks CardioComms second successful launch of
an internationally-accessible ECG management solution. The first was the release
of CardioComms FDA-cleared Global Cardio 12-lead solution (GC12). GC12 enables
remote recording of ECGs up to a 12-lead configuration from any location, and
with physician access to these ECGs over the internet. The applicability of
GC12 is limitless and includes in-hospital, satellite clinic, and in-ambulance
monitoring.
More Information
For more information on any CardioComm product or service, call 1-877-977-9425
toll free in the U.S. and Canada, or
email [email protected].
About CardioComm Solutions, Inc.
CardioComm is a leading provider of innovative hardware and software solutions
for cardiovascular health management. The firms patented and proprietary
technology is used in products for recording, viewing, analyzing and storing
electrocardiograms (ECGs) for diagnosis and management of cardiac patients.
Products are sold worldwide through a combination of an external distribution
network and a North American-based sales team. The company has earned the ISO
13485 certification, is HPB approved, HIPAA compliant, and has received FDA
market clearance for its software devices.
CardioComm Solutions, Inc. is headquartered in Toronto, Canada,
with offices in Victoria,
B.C.
